AU4061085A - Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the receptor of polymerized human serum albumin, animal cells capable of producing such particles and method for the obtention thereof - Google Patents
Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the receptor of polymerized human serum albumin, animal cells capable of producing such particles and method for the obtention thereofInfo
- Publication number
- AU4061085A AU4061085A AU40610/85A AU4061085A AU4061085A AU 4061085 A AU4061085 A AU 4061085A AU 40610/85 A AU40610/85 A AU 40610/85A AU 4061085 A AU4061085 A AU 4061085A AU 4061085 A AU4061085 A AU 4061085A
- Authority
- AU
- Australia
- Prior art keywords
- particles
- hepatitis
- receptor
- antigene
- obtention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 title abstract 5
- 102000008100 Human Serum Albumin Human genes 0.000 title abstract 2
- 108091006905 Human Serum Albumin Proteins 0.000 title abstract 2
- 210000004102 animal cell Anatomy 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000700721 Hepatitis B virus Species 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 101710132601 Capsid protein Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Compsn. for vaccine prodn. comprises (or contains) polypeptide particles which are practically spherical (at least those having immunogenic and immunological characteristics of hepatitis B surface antigen) with diam. 18-25 (pref. 20-22)nm and density allowing sepn. in a density region 1.2-1.22 g/ml in a CsCl gradient. The compsn. is totally free of Dane particles and of envelope antigen (including core antigen), and the particles also contain a receptor for polymerised human albumin. Also new are (1) vectors for transforming eucaryotic cells contg. a DNA sequence coding for the S and pre-S regions of HBV under direct control of an exogenous promoter which is very efficient for expression in the intended animal host cells and (2) animal cell lines transformed with these vectors.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8403564 | 1984-03-07 | ||
FR8403564A FR2560890B1 (en) | 1984-03-07 | 1984-03-07 | COMPOSITION USEFUL FOR THE MANUFACTURE OF VACCINES CONTAINING PARTICLES CARRYING THE SURFACE ANTIGEN OF HEPATITIS B VIRUS AND THE POLYMERIZED HUMAN SERUM ALBUMIN RECEPTOR, ANIMAL CELLS CAPABLE OF PRODUCING SUCH PARTICLES |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4061085A true AU4061085A (en) | 1985-09-24 |
AU598181B2 AU598181B2 (en) | 1990-06-21 |
Family
ID=9301807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU40610/85A Expired AU598181B2 (en) | 1984-03-07 | 1985-03-07 | Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the receptor of polymerized human serum albumin, animal cells capable of producing such particles and method for the obtention thereof |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP0156712B1 (en) |
JP (1) | JPH08839B2 (en) |
KR (1) | KR930003609B1 (en) |
AT (1) | ATE141168T1 (en) |
AU (1) | AU598181B2 (en) |
CA (1) | CA1262532A (en) |
DE (1) | DE3588117T2 (en) |
FR (1) | FR2560890B1 (en) |
SU (1) | SU1625332A3 (en) |
WO (1) | WO1985003876A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619753B2 (en) * | 1987-06-22 | 1992-02-06 | Medeva Holdings B.V. | Hepatitis b surface antigen vaccine |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL79740A0 (en) * | 1986-08-17 | 1986-11-30 | Yeda Res & Dev | Hepatitis vaccine |
FR2608052B1 (en) * | 1986-12-10 | 1990-04-13 | Pasteur Vaccins | PROCESS FOR THE PREPARATION OF A HEPATITIS B VACCINE AND VACCINE OBTAINED |
EP1088830A3 (en) * | 1987-06-22 | 2004-04-07 | Medeva Holdings B.V. | Hepatitis b surface antigen particles |
CA1341074C (en) | 1987-06-22 | 2000-08-08 | Hans A. Thoma | Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine |
JPH0216975A (en) * | 1988-02-09 | 1990-01-19 | Eugene Tech Internatl Inc | B-type hepatitis surface antigen rich in play s of different component mixing properties |
EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
FR2711670B1 (en) | 1993-10-22 | 1996-01-12 | Pasteur Institut | Nucleotide vector, composition containing it and vaccine for immunization against hepatitis. |
JP4085231B2 (en) * | 2000-02-28 | 2008-05-14 | 株式会社ビークル | Protein hollow nanoparticles, substance carrier using the same, and method for introducing substance into cells |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4113712A (en) * | 1976-03-08 | 1978-09-12 | The Green Cross Corporation | HBsAG Particle composed of single polypeptide subunits and the preparation procedure |
CA1100037A (en) * | 1977-03-11 | 1981-04-28 | Chung-Mei Ling | Hb.sub.c ag coated on solid phase |
IL59007A (en) * | 1978-12-22 | 1983-11-30 | Biogen Nv | Recombinant dna molecules coding for polypeptides displaying hepatitis b virus antigenicity,method of their production and compositions containing the same |
JPS5610119A (en) * | 1979-07-05 | 1981-02-02 | Alpha Therapeutic Corp | Manufacture of b type hepatitis infection preventive vaccine |
FR2480780B1 (en) * | 1980-04-22 | 1985-12-06 | Pasteur Institut | PROCESS FOR THE TRANSFORMATION OF CELLS, ESPECIALLY EUKARYOTES, BY CIRCULAR DNA SUCH AS THAT OF HEPATITIS B VIRUS AND PREPARATIONS CONTAINING THE EXPRESSION PRODUCTS OF SAID DNA |
DE3176404D1 (en) * | 1980-04-22 | 1987-10-08 | Pasteur Institut | Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine |
ZW18282A1 (en) * | 1981-08-31 | 1983-03-23 | Genentech Inc | Preparation of polypeptides in vertebrate cell culture |
JPS5936698A (en) * | 1982-08-20 | 1984-02-28 | Science & Tech Agency | Recombinant dna recombined with gene of virus of hepatitis b, transformed animal cell, and preparation of protein of virus of hepatitis b |
US4847080A (en) * | 1984-03-07 | 1989-07-11 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers |
WO1985004103A1 (en) * | 1984-03-09 | 1985-09-26 | Scripps Clinic And Research Foundation | Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants |
NL8401066A (en) * | 1984-04-04 | 1985-11-01 | Stichting Centraal Lab | PROCESS FOR PREPARING PREPARATIONS INCREASING HUMORAL AND CELLULAR IMMUNE ACTIVITY |
-
1984
- 1984-03-07 FR FR8403564A patent/FR2560890B1/en not_active Expired
-
1985
- 1985-03-07 JP JP60501078A patent/JPH08839B2/en not_active Expired - Lifetime
- 1985-03-07 AT AT85400444T patent/ATE141168T1/en not_active IP Right Cessation
- 1985-03-07 EP EP85400444A patent/EP0156712B1/en not_active Expired - Lifetime
- 1985-03-07 WO PCT/FR1985/000044 patent/WO1985003876A1/en unknown
- 1985-03-07 DE DE3588117T patent/DE3588117T2/en not_active Expired - Lifetime
- 1985-03-07 AU AU40610/85A patent/AU598181B2/en not_active Expired
- 1985-03-07 EP EP95120494A patent/EP0732104A1/en not_active Withdrawn
- 1985-03-07 CA CA000475890A patent/CA1262532A/en not_active Expired
- 1985-11-06 KR KR1019850700290A patent/KR930003609B1/en not_active IP Right Cessation
- 1985-11-06 SU SU854011814A patent/SU1625332A3/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619753B2 (en) * | 1987-06-22 | 1992-02-06 | Medeva Holdings B.V. | Hepatitis b surface antigen vaccine |
Also Published As
Publication number | Publication date |
---|---|
WO1985003876A1 (en) | 1985-09-12 |
DE3588117T2 (en) | 1997-03-20 |
DE3588117D1 (en) | 1996-09-19 |
JPH08839B2 (en) | 1996-01-10 |
EP0732104A1 (en) | 1996-09-18 |
FR2560890A1 (en) | 1985-09-13 |
EP0156712B1 (en) | 1996-08-14 |
CA1262532A (en) | 1989-10-31 |
FR2560890B1 (en) | 1987-10-16 |
KR850700214A (en) | 1985-12-26 |
KR930003609B1 (en) | 1993-05-08 |
JPS61500971A (en) | 1986-05-15 |
SU1625332A3 (en) | 1991-01-30 |
EP0156712A1 (en) | 1985-10-02 |
ATE141168T1 (en) | 1996-08-15 |
AU598181B2 (en) | 1990-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU598181B2 (en) | Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the receptor of polymerized human serum albumin, animal cells capable of producing such particles and method for the obtention thereof | |
EP0291586A3 (en) | Recombinant hepatitis b surface antigen and vaccine containing it | |
AU7752894A (en) | Novel antigens and methods thereof | |
DE3280284D1 (en) | MANUFACTURE OF SURFACE HEPATITIS B ANTIGES IN YEAST. | |
ES514712A0 (en) | PREPARATION PROCEDURE FOR HB1AG (HEPATITIS B SURFACE ANTIGEN). | |
ATE70308T1 (en) | HYBRID PARTICLE IMMUNOGENS. | |
AU6781990A (en) | Toxoplasma gondii antigens, the preparation thereof and the use thereof | |
PT82500A (en) | PARTICLES HAVING IMMUNOGENIC PROPERTIES OF ANTIGEN HBS AND CARRYING AN ANTIGENIC SITE FOREIGNING WITH THE ANTIGEN-HBS VECTORS AND AN9MAL5S CELLS POU9-3- & 7RO4D3C9ON OF SUCH PARTICLES AND COMPOSITIONS CONTAINING SUCH PARTICLES FOR THE PRODUCTION OF MIXED VACCINES | |
EP0106828A3 (en) | Recombinant dna molecules encoding for hepatitis b surface antigen, their preparation and derived vaccines | |
ATE122568T1 (en) | POLYPEPTIDES, ANTIGENS OR VACCINES AGAINST BABESIOSIS. | |
ATE73349T1 (en) | HEPATITIS SURFACE ANTIGEN PARTICLE VACCINATION. | |
EP0062574A3 (en) | Virus protein synthesis | |
ES8602935A1 (en) | Shuttle vector | |
Stratowa et al. | Expression of hepatitis-B-surface antigen in eukaryotic cells using viral vectors. | |
IT1165451B (en) | Vaccinia virus modified with exogenous DNA in vaccinia genome | |
ATE53235T1 (en) | SYNTHESIS OF HUMAN VIRAL ANTIGENS USING YEAST. |